Mobile fosfomycin resistance genes in Enterobacteriaceae-An increasing threat.
Enterobacteriaceae
antimicrobial resistance
dissemination
transferrable fosfomycin resistance
Journal
MicrobiologyOpen
ISSN: 2045-8827
Titre abrégé: Microbiologyopen
Pays: England
ID NLM: 101588314
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
31
07
2020
revised:
25
09
2020
accepted:
12
10
2020
pubmed:
1
11
2020
medline:
17
8
2021
entrez:
31
10
2020
Statut:
ppublish
Résumé
Antimicrobial resistance is one of the major threats to the health and welfare of both humans and animals. The shortage of new antimicrobial agents has led to the re-evaluation of old antibiotics such as fosfomycin as a potential regimen for treating multidrug-resistant bacteria especially extended-spectrum-beta-lactamase- and carbapenemase-producing Enterobacteriaceae. Fosfomycin is a broad-spectrum bactericidal antibiotic that inhibits the initial step of the cell wall biosynthesis. Fosfomycin resistance can occur due to mutation in the drug uptake system or by the acquisition of fosfomycin-modifying enzymes. In this review, we focus on mobile fosfomycin-resistant genes encoding glutathione-S-transferase which are mainly responsible for fosfomycin resistance in Enterobacteriaceae, that is, fosA and its subtypes, fosC2, and the recently described fosL1-L2. We summarized the proposed origins of the different resistance determinants and highlighted the different plasmid types which are attributed to the dissemination of fosfomycin-modifying enzymes. Thereby, IncF and IncN plasmids play a predominant role. The detection of mobile fosfomycin-resistant genes in Enterobacteriaceae has increased in recent years. Similar to the situation in (East) Asia, the most frequently detected fosfomycin-resistant gene in Europe is fosA3. Mobile fosfomycin-resistant genes have been detected in isolates of human, animal, food, and environmental origin which leads to a growing concern regarding the risk of spread of such bacteria, especially Escherichia coli and Salmonella, at the human-animal-environment interface.
Identifiants
pubmed: 33128341
doi: 10.1002/mbo3.1135
pmc: PMC7755807
doi:
Substances chimiques
Anti-Bacterial Agents
0
Escherichia coli Proteins
0
FosA(3) protein, E coli
0
Fosfomycin
2N81MY12TE
Glutathione Transferase
EC 2.5.1.18
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1135Informations de copyright
© 2020 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd.
Références
mBio. 2017 Aug 29;8(4):
pubmed: 28851843
Antimicrob Agents Chemother. 2018 Mar 27;62(4):
pubmed: 29378715
Antimicrob Agents Chemother. 1980 Aug;18(2):215-9
pubmed: 7004337
Antimicrob Agents Chemother. 2012 Apr;56(4):2135-8
pubmed: 22232290
Int J Antimicrob Agents. 2015 Jan;45(1):25-32
pubmed: 25465520
Antimicrob Agents Chemother. 2000 Mar;44(3):647-50
pubmed: 10681332
Vet Microbiol. 2020 Apr;243:108619
pubmed: 32273005
Microbiol Spectr. 2018 Jul;6(4):
pubmed: 30003866
J Antimicrob Chemother. 1997 Sep;40(3):393-9
pubmed: 9338493
J Med Microbiol. 2018 Aug;67(8):1031-1041
pubmed: 29927373
Methods Enzymol. 2005;401:367-79
pubmed: 16399398
Antibiotics (Basel). 2013 Apr 16;2(2):217-36
pubmed: 27029300
Eur J Clin Microbiol Infect Dis. 2019 May;38(5):945-949
pubmed: 30877486
J Appl Microbiol. 2013 Mar;114(3):695-702
pubmed: 23216653
Ann N Y Acad Sci. 1974 May 10;235(0):364-86
pubmed: 4605290
Clin Microbiol Infect. 2015 Oct;21(10):899-905
pubmed: 26027916
J Antimicrob Chemother. 2016 Sep;71(9):2460-5
pubmed: 27261267
Int J Med Microbiol. 2013 Aug;303(6-7):298-304
pubmed: 23499304
Antimicrob Agents Chemother. 1990 Oct;34(10):2016-8
pubmed: 1963292
J Antimicrob Chemother. 2018 Apr 1;73(4):867-872
pubmed: 29340602
Int J Infect Dis. 2011 Nov;15(11):e732-9
pubmed: 21945848
J Glob Antimicrob Resist. 2018 Mar;12:183-184
pubmed: 29412182
J Antimicrob Chemother. 2010 Jun;65(6):1155-61
pubmed: 20356905
Vet Microbiol. 2018 Jun;219:63-69
pubmed: 29778206
Antimicrob Agents Chemother. 2020 Mar 24;64(4):
pubmed: 31932373
Antimicrob Agents Chemother. 2012 May;56(5):2767-9
pubmed: 22371901
Open Vet J. 2014;4(1):26-43
pubmed: 26623336
Antimicrob Agents Chemother. 2017 Jun 27;61(7):
pubmed: 28483962
Antimicrob Agents Chemother. 2010 Jul;54(7):3061-4
pubmed: 20404116
J Antimicrob Chemother. 2018 Feb 1;73(2):373-376
pubmed: 29106538
Antimicrob Agents Chemother. 2014 Sep;58(9):5638-9
pubmed: 24982077
Vet Microbiol. 2013 Mar 23;162(2-4):964-967
pubmed: 23078751
PLoS One. 2015 Dec 30;10(12):e0144802
pubmed: 26716443
J Antimicrob Chemother. 2018 May 1;73(5):1121-1137
pubmed: 29370371
Eur J Clin Microbiol Infect Dis. 2012 May;31(5):695-701
pubmed: 21805292
Antimicrob Agents Chemother. 2019 Oct 22;63(11):
pubmed: 31481445
J Med Microbiol. 2013 Nov;62(Pt 11):1707-1713
pubmed: 23988630
Antimicrob Agents Chemother. 2015 Oct;59(10):6597-600
pubmed: 26169417
J Glob Antimicrob Resist. 2020 Jun;21:414-416
pubmed: 32061811
EFSA J. 2018 Feb 27;16(2):e05182
pubmed: 32625816
J Antimicrob Chemother. 2012 Dec;67(12):2843-7
pubmed: 22893681
J Clin Microbiol. 2014 Sep;52(9):3175-9
pubmed: 24951800
Infect Drug Resist. 2020 May 01;13:1273-1279
pubmed: 32431524
Front Microbiol. 2017 Jul 13;8:1322
pubmed: 28751886
Emerg Infect Dis. 2017 Sep;23(9):1564-1567
pubmed: 28820368
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29866858
J Microbiol Immunol Infect. 2019 Feb;52(1):9-21
pubmed: 29198952
J Antimicrob Chemother. 2013 Apr;68(4):766-70
pubmed: 23190765
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28674050
Lancet Infect Dis. 2010 Jan;10(1):43-50
pubmed: 20129148
Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):
pubmed: 28062557
Antimicrob Agents Chemother. 2003 Sep;47(9):2850-8
pubmed: 12936984
J Antimicrob Chemother. 2019 Dec 1;74(12):3630-3632
pubmed: 31511878
Front Microbiol. 2014 Dec 16;5:688
pubmed: 25566207
Emerg Infect Dis. 2016 Feb;22(2):346-8
pubmed: 26812028
Lett Appl Microbiol. 2015 Mar;60(3):259-64
pubmed: 25441705